David Goldstein

31.6k citations
449 papers · 18.9k · 4 hit papers · h-index 64

Impact in

  • Oncology top 0.05%
    • Pancreatic and Hepatic Oncology Research
    • Cancer Treatment and Pharmacology
    • Cancer survivorship and care
    • Cancer Cells and Metastasis
    • Colorectal Cancer Treatments and Studies
    • Cancer Genomics and Diagnostics

Papers in

    • Pancreatic and Hepatic Oncology Research 96
    • Cancer Treatment and Pharmacology 69
    • Colorectal Cancer Treatments and Studies 35
    • Cancer survivorship and care 22
    • Cancer Cells and Metastasis 15
    • Gastric Cancer Management and Outcomes 23

David Goldstein

430 papers receiving 18.4k citations

David Goldstein's Hit Papers

Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib 2016 · 706 citations
7060+6+12Years since publication50010001.5k2.0k2.5k

Peers

David Goldstein
Comparison fields: 5 of 203
  • Oncology 9.9k
  • Cancer Research 1.9k
  • Gastroenterology 541
  • Pulmonary and Respiratory Medicine 2.4k
  • Hepatology 447
Replace Alfred Rademaker with:
Alfred Rademaker United States
William C. Wood United States
Winette T.A. van der Graaf Netherlands
Charis Eng United States
Paul J. Christos United States
David P. Ryan United States
Deepa Naishadham United States
David Osoba Canada
Michael Friedländer Australia
Fang Fang China
David Goldstein relative to Alfred Rademaker United States Alfred Rademaker's profile →
Citations per field
00.5×1.5×2.3×
Alfred Rademaker · 1×
Citations per year

Countries citing papers authored by David Goldstein

Since Specialization
Citations

This map shows the geographic impact of David Goldstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Goldstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Goldstein more than expected).

Fields of papers citing papers by David Goldstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Goldstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Goldstein. The network helps show where David Goldstein may publish in the future.

Co-authors

The 25 scholars most cited alongside David Goldstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with David Goldstein Line = papers co-authored together David Goldstein links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 449 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Erlotinib Plus Gemcitabine Compared With Gemcitabine Alone in Patients With Advanced Pancreatic Cancer: A Phase III Trial of the National Cancer Institute of Canada Clinical Trials Group
Hit paper breakdown →
20072920
2
Effect of Chemoradiotherapy vs Chemotherapy on Survival in Patients With Locally Advanced Pancreatic Cancer Controlled After 4 Months of Gemcitabine With or Without Erlotinib
Hit paper breakdown →
2016706
3
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Hit paper breakdown →
2013566
4
nab-Paclitaxel Plus Gemcitabine for Metastatic Pancreatic Cancer: Long-Term Survival From a Phase III Trial
Hit paper breakdown →
2015510
5 2004490
6 2004405
7 2008395
8 2010289
9 2005222
10 2002211
11 2011207
12 2017206
13 2005201
14 2017199
15 2009192
16 2008178
17 2012175
18 1990172
19 2005162
20 2011162

About David Goldstein

David Goldstein is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Surgery and Public Health, Environmental and Occupational Health, having authored 449 papers that have together received 18.9k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (96 papers), Cancer Treatment and Pharmacology (69 papers), Cancer Genomics and Diagnostics (44 papers), Colorectal Cancer Treatments and Studies (35 papers), Gastric Cancer Management and Outcomes (23 papers), Cancer survivorship and care (22 papers), Gastrointestinal Tumor Research and Treatment (21 papers) and Cancer Cells and Metastasis (15 papers). The work is most often cited by research in Oncology (9.9k citations), Cancer Research (1.9k citations), Gastroenterology (541 citations), Pulmonary and Respiratory Medicine (2.4k citations) and Hepatology (447 citations). David Goldstein has collaborated with scholars based in Australia, United States and Canada. Frequent co-authors include Susanna B. Park, Michael Friedländer, Matthew C. Kiernan, Phyllis Butow, Arun V. Krishnan, Minoti V. Apte, Malcolm J. Moore, Jeremy S. Wilson, Romano C. Pirola and Cindy Lin. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Supportive Care in Cancer, European Journal of Cancer and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact